Werewolf Therapeutics, Inc. (HOWL) Misses Q1 EPS by 1c

Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q1 EPS of ($0.28), $0.01 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.

You May Also Be Interested In

• Kushner: conversations between U.S. and different areas of Iran govt are more robust than it has every been
• argenx SE (ARGX) PT Raised to $1,115 at Leerink
• Trump on North Korea's Kim Jong Un: he has responded to me